Instrumentation Laboratory (IL) has acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem), a global leader in in vitro diagnostic (IVD) testing for patient blood management (PBM), according to a company press release. Tem manufacturers the Rotem testing systems.
The move allows IL to expand its product line in Hemostasis and Critical Care IVD, the company said.
In hospital trauma and surgical patients with clinically significant bleeding, Rotem whole blood analyzers provide a rapid differential diagnosis of coagulopathies, IL reports. This supports targeted transfusion and coagulation factor concentrate therapy and, as a result, is key to PBM programs.
IL believes proper PBM minimizes blood loss and thereby significantly reduces or avoids blood transfusion, which can lead to avoidable complications and increase in morbidity, mortality, and overall hospital costs.